Daryl Saylor is a partner in Lash & Goldberg LLP’s Fort Lauderdale office. Prior to the joining the Firm, Daryl practiced at two global law firms, DLA Piper LLP and Fried, Frank, Harris, Shriver & Jacobson LLP.
Daryl represents global and national companies, boards, agencies, government contractors, executives, officers, directors and individuals in high stakes lawsuits/appeals, government enforcement actions, and internal investigations relating to the False Claims Act (FCA), Stark Law (Stark), Anti-Kickback Statute (AKS), Foreign Corrupt Practices Act (FCPA), Sherman Act, fraud, breach of contract, securities, corporate governance, deceptive trade practices, real estate, and employment. His experience spans multiple sectors, including, without limitation, healthcare, pharmaceuticals, banking, securities, professional services, real estate, oil and gas, telecommunications, entertainment, and hospitality.
Daryl focuses a large portion of his practice on defending high stakes FCA actions/investigations. He regularly handles all aspects of such matters, including complex investigations while complaints are under seal, dispositive motions, trials, appeals and the negotiation of settlement agreements. He has litigated these kind of actions concerning numerous federal healthcare reimbursement programs (Medicare Parts A, B, and C, Medicaid, Tricare, Champ VA, Veteran’s Choice, and the Federal Railroad Retirement Program) and virtually every type of cause of action (31 U.S.C. §§ 3729(a)(1)(A), (false claims), (a)(1)(B) (false records), (a)(1)(C) (conspiracy), (a)(1)(G) (reverse false claims), 31 U.S.C. § 3730 (retaliation), 42 U.S.C. § 1395nn (Stark), and 42 U.S.C. § 1320a-7b(b) (AKS)).
Daryl also conducts internal investigations – both on a domestic and global scale – assisting clients gather facts, perform remediation as necessary, and respond to civil investigate demands, grand jury subpoenas, administrative subpoenas, and other requests served by the U.S. Department of Justice, the U.S. HHS Office of Inspector General, the Centers for Medicare & Medicaid Services, the U.S. Securities & Exchange Commission, U.S. Attorneys’ Offices, states’ attorneys general offices, and other foreign enforcement bodies.